Isoginkgetin has been identified as a general inhibitor of pre-mRNA splicing using an in vivo screening assay. This and related inhibitors will not only be useful as tools to decipher the roles of the individual components of the spliceosome but may also serve as therapeutics.
References
O' Brien, K., Matlin, A.J., Lowell, A.M. & Moore, M.J. J. Biol. Chem. published online, doi:10.1074/jbc.M805556200 (30 September 2008).
Yoshizawa, S., Fourmy, D. & Puglisi, J.D. Science 285, 1722–1725 (1999).
Moazed, D. & Noller, H.F. Nature 342, 142–148 (1989).
Douthwaite, S., Prince, J.B. & Noller, H.F. Proc. Natl. Acad. Sci. USA 82, 8330–8334 (1985).
Ermolenko, D.N. et al. Nat. Struct. Mol. Biol. 14, 493–497 (2007).
Kotake, Y. et al. Nat. Chem. Biol. 3, 570–575 (2007).
Kaida, D. et al. Nat. Chem. Biol. 3, 576–583 (2007).
Albert, B.J., Sivaramakrishnan, A., Naka, T., Czaicki, N.L. & Koide, K. J. Am. Chem. Soc. 129, 2648–2659 (2007).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Disney, M. Short-circuiting RNA splicing. Nat Chem Biol 4, 723–724 (2008). https://doi.org/10.1038/nchembio1208-723
Issue Date:
DOI: https://doi.org/10.1038/nchembio1208-723
- Springer Nature America, Inc.
This article is cited by
-
Structural basis of a small molecule targeting RNA for a specific splicing correction
Nature Chemical Biology (2019)
-
Total RNA-seq to identify pharmacological effects on specific stages of mRNA synthesis
Nature Chemical Biology (2017)